119 related articles for article (PubMed ID: 35148662)
1. Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study.
Mikkola I; Morgan S; Winell K; Jokelainen J; Frittitta L; Heikkala E; Hagnäs M
Scand J Prim Health Care; 2022 Mar; 40(1):39-47. PubMed ID: 35148662
[TBL] [Abstract][Full Text] [Related]
2. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study.
Heikkala E; Mikkola I; Jokelainen J; Timonen M; Hagnäs M
BMC Health Serv Res; 2021 Sep; 21(1):964. PubMed ID: 34521389
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study.
Vuohijoki A; Mikkola I; Jokelainen J; Keinänen-Kiukaanniemi S; Winell K; Frittitta L; Timonen M; Hagnäs M
J Prim Care Community Health; 2020; 11():2150132720921700. PubMed ID: 32450742
[No Abstract] [Full Text] [Related]
4. Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population.
Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
Scand J Prim Health Care; 2016 Sep; 34(3):267-73. PubMed ID: 27404014
[TBL] [Abstract][Full Text] [Related]
5. Association of musculoskeletal pain with the achievement of treatment targets for type 2 diabetes among primary care patients.
Heikkala E; Hagnäs M; Jokelainen J; Karppinen J; Ferreira P; Ferreira ML; Mikkola I
Prim Care Diabetes; 2022 Aug; 16(4):531-536. PubMed ID: 35523651
[TBL] [Abstract][Full Text] [Related]
6. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
[TBL] [Abstract][Full Text] [Related]
7. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
[TBL] [Abstract][Full Text] [Related]
8. Recurrent prescription of sleep medication among primary care patients with type 2 diabetes: an observational study of real-world registry data.
Heikkala E; Jokelainen J; Mikkola I; Auvinen J; Hagnäs M
BMC Prim Care; 2023 Apr; 24(1):90. PubMed ID: 37016350
[TBL] [Abstract][Full Text] [Related]
9. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Rotunno T; Khoan J; Hirsch JD
Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
[TBL] [Abstract][Full Text] [Related]
10. Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study.
Cheng AYY; Goldenberg R; Krawchenko I; Tytus R; Hahn J; Liu A; Golden S; Millson B; Harris S
Can J Diabetes; 2023 Jul; 47(5):398-404. PubMed ID: 36958421
[TBL] [Abstract][Full Text] [Related]
11. Real world clinical outcomes and patient characteristics for canagliflozin treated patients in a specialty diabetes clinic.
Johnson JF; Parsa R; Bailey R
Curr Med Res Opin; 2017 Jan; 33(1):77-84. PubMed ID: 27646315
[TBL] [Abstract][Full Text] [Related]
12. Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement.
Leiter LA; Cheng AYY; Ekoé JM; Goldenberg RM; Harris SB; Hramiak IM; Khunti K; Lin PJ; Richard JF; Senior PA; Yale JF; Goldin L; Tan MK; Langer A
Can J Diabetes; 2019 Aug; 43(6):384-391. PubMed ID: 30554985
[TBL] [Abstract][Full Text] [Related]
13. Personalised treatment targets in type 2 diabetes patients: The Dutch approach.
Boels AM; Hart HE; Rutten GE; Vos RC
Prim Care Diabetes; 2017 Feb; 11(1):71-77. PubMed ID: 27633894
[TBL] [Abstract][Full Text] [Related]
14. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
[TBL] [Abstract][Full Text] [Related]
15. A Personalized Care Plan Is Positively Associated With Better Clinical Outcomes in the Care of Patients With Type 2 Diabetes: A Cross-Sectional Real-Life Study.
Mikkola I; Hagnäs M; Hartsenko J; Kaila M; Winell K
Can J Diabetes; 2020 Mar; 44(2):133-138. PubMed ID: 31399365
[TBL] [Abstract][Full Text] [Related]
16. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
[TBL] [Abstract][Full Text] [Related]
17. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.
Minutolo R; Sasso FC; Chiodini P; Cianciaruso B; Carbonara O; Zamboli P; Tirino G; Pota A; Torella R; Conte G; De Nicola L
J Hypertens; 2006 Aug; 24(8):1655-61. PubMed ID: 16877970
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
Luo J; Khan NF; Manetti T; Rose J; Kaloghlian A; Gadhe B; Jain SH; Gagne JJ; Kesselheim AS
JAMA; 2019 Jan; 321(4):374-384. PubMed ID: 30694321
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of standardized nursing care plans to achieve A1C, blood pressure, and LDL-C goals among people with poorly controlled type 2 diabetes mellitus at baseline: four-year follow-up study.
Cárdenas-Valladolid J; López-de Andrés A; Jiménez-García R; de Dios-Duarte MJ; Gómez-Campelo P; de Burgos-Lunar C; San Andrés-Rebollo FJ; Abánades-Herranz JC; Salinero-Fort MA
BMC Fam Pract; 2018 Jul; 19(1):125. PubMed ID: 30041600
[TBL] [Abstract][Full Text] [Related]
20. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
Safai N; Carstensen B; Vestergaard H; Ridderstråle M
BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
